These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Distribution of acetylcholine receptors at frog neuromuscular junctions with a discussion of some physiological implications. Matthews-Bellinger J, Salpeter MM. J Physiol; 1978 Jun; 279():197-213. PubMed ID: 307600 [Abstract] [Full Text] [Related]
9. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M. Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584 [Abstract] [Full Text] [Related]
10. In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis. Rich MM, Colman H, Lichtman JW. Neurology; 1994 Nov; 44(11):2138-45. PubMed ID: 7969973 [Abstract] [Full Text] [Related]
11. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Engel AG, Lambert EH, Howard FM. Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771 [Abstract] [Full Text] [Related]
13. Myasthenia gravis and myasthenic syndromes. Engel AG. Ann Neurol; 1984 Nov; 16(5):519-34. PubMed ID: 6095730 [Abstract] [Full Text] [Related]
14. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME. J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896 [Abstract] [Full Text] [Related]
15. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia. Vincent A. J Recept Res; 1987 Sep 01; 7(1-4):599-616. PubMed ID: 2442386 [Abstract] [Full Text] [Related]
16. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG, Tsujihata M, Lindstrom JM, Lennon VA. Ann N Y Acad Sci; 1976 Sep 01; 274():60-79. PubMed ID: 1066997 [Abstract] [Full Text] [Related]
17. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice. Berman PW, Heinemann SF. J Immunol; 1984 Feb 01; 132(2):711-7. PubMed ID: 6690616 [Abstract] [Full Text] [Related]
18. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities]. Yoshimura T, Motomura M, Tsujihata M. Brain Nerve; 2011 Jul 01; 63(7):719-27. PubMed ID: 21747142 [Abstract] [Full Text] [Related]
19. Different degradation rates of junctional and extrajunctional acetylcholine receptors of human muscle cultured in monolayer and innervated by fetal rat spinal cord neurons. Braun S, Askanas V, Engel WK. Int J Dev Neurosci; 1992 Jul 01; 10(1):37-44. PubMed ID: 1609620 [Abstract] [Full Text] [Related]
20. Age-related resistance to experimental autoimmune myasthenia gravis in rats. Graus YM, Verschuuren JJ, Spaans F, Jennekens F, van Breda Vriesman PJ, De Baets MH. J Immunol; 1993 May 01; 150(9):4093-103. PubMed ID: 8386206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]